What does PPTP mean in PEDIATRIC

The Pediatric Preclinical Testing Program (PPTP) is a research program designed to advance the development of drugs and biologics for pediatric illnesses. It offers pre-clinical services such as consulting, design and analysis of animal studies, production of required reagents, and assistance with regulatory submissions.

PPTP helps advance drug development for pediatric illnesses by providing comprehensive pre-clinical services that are tailored to meet the specific requirements of each project. These services include consultation on study design; analysis of data from animal studies; production of required reagents; and assistance with regulatory submissions.

PPTP benefits pharmaceutical companies, biotechnology companies, CROs, academic researchers, and government agencies working on pediatric drug development projects. It provides a comprehensive suite of pre-clinical services tailored to meet the needs of each project.

Yes, there is a fee associated with using PPTP’s services. However, fees can be negotiated depending on the nature and complexity of the project. In addition, compared to private industry resources there are likely cost savings associated with using PPTP’s services due to its lower overhead costs.

Organizations can apply for access to PPTP’s services by submitting an online proposal form that includes basic demographic information as well as details about their research project or product/device development plans. Once submitted, proposals will go through review by project scientists at various stages before approval can be granted for use of PPPT’s resources and expertise.

The length of time it takes to get approved after submitting an application depends on several factors including the type/scope of research being proposed and any additional information needed from the applicant organization or its sponsors prior to approval being granted. On average it may take two weeks or more until review is completed and an approval can be given for use of PPTP’s resources and expertise.

Yes, once an organization has been approved for access they will be invited to schedule regular in-person meetings with assigned project scientists who will assist them throughout the duration of their research project or product/device development plan. This includes conducting presentations detailing proposed goals/experiments as well as discussing results obtained during animal studies or experiments conducted outside of PPTP's laboratory facilities.

Yes, in some cases sample materials needed for testing products/devices may be provided by PEPT if available within its inventory or requested from external sources at no additional charge other than shipping expenses associated with these requests if applicable. All samples must first pass relevant safety checks before being released from PEPT's labs according to established protocols before any usage is allowed within laboratory settings outside PEPT's facility walls if applicable.

There is no set limit in terms of how long organizations have access to utilize PEPT’s pre-clinical testing resources and expertise however projects must meet reasonable deadlines which are agreed upon prior to beginning work during initial planning meetings between representatives from PEPT and those seeking utilization rights via submitted applications.